• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
49,248.22 -970.95
(-1.93%)
Dow Jones
7,218.05 -126.58
(-1.72%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,468.58 -82.59
(-0.78%)
Forex
USD-INR
93.42 -0.12
(-0.13%)
EUR-INR
102.53 -0.37
(-0.36%)
GBP-INR
123.02 -0.43
(-0.35%)
JPY-INR
0.59 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Prism Medico & Pharmacy Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
512217
INE730E01016
24.3886929
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
47.4
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Urja Global consolidated net profit rises 66.67% in the March 2026 quarter
May 22,2026
Net profit of Urja Global rose 66.67% to Rs 0.20 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales rose 2.33% to Rs 17.58 crore in the quarter ended March 2026 as against Rs 17.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.51% to Rs 1.34 crore in the year ended March 2026 as against Rs 1.27 crore during the previous year ended March 2025. Sales declined 0.82% to Rs 66.70 crore in the year ended March 2026 as against Rs 67.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17.5817.18 2 66.7067.25 -1
OPM %2.674.13 -3.192.66 -
PBDT0.470.92 -49 2.482.41 3
PBT0.360.81 -56 1.992.03 -2
NP0.200.12 67 1.341.27 6